StockData
Arcadia Biosciences, Inc. logo

Arcadia Biosciences, Inc. (RKDA) stock

RKDANasdaqBeveragesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.19−0.00 (-2.01%)

Close on Nov 17, 2026Market cap $457.03KP/E –Yield –

Arcadia Biosciences r&d expenses

Research and development expenses are spending on new products and technology.

Arcadia Biosciences's R&D Expenses for the twelve months ending Dec 31, 2025 was $9.00K, down 83.0% year over year. For fiscal 2025 it was $9.00K, down 83.0% from the year before. Over ten years it grew -49.9% a year on average. The highest annual figure on record is $10.01M in fiscal 2014.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$9.00K-83.0%
FY2024Dec 31, 2024$53.00K-17.2%
FY2023Dec 31, 2023$64.00K-95.8%
FY2022Dec 31, 2022$1.51M-61.2%
FY2021Dec 31, 2021$3.89M-51.1%
FY2020Dec 31, 2020$7.96M+12.1%
FY2019Dec 31, 2019$7.10M+17.0%
FY2018Dec 31, 2018$6.07M-18.1%
FY2017Dec 31, 2017$7.41M-14.5%
FY2016Dec 31, 2016$8.66M-3.4%
FY2015Dec 31, 2015$8.97M-10.4%
FY2014Dec 31, 2014$10.01M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$0–
Q4 FY2025Dec 31, 2025$0-100.0%
Q3 FY2025Sep 30, 2025$0-100.0%
Q2 FY2025Jun 30, 2025$9.00K-10.0%
Q1 FY2025Mar 31, 2025$0-100.0%
Q4 FY2024Dec 31, 2024$13.00K+44.4%
Q3 FY2024Sep 30, 2024$24.00K+60.0%
Q2 FY2024Jun 30, 2024$10.00K-63.0%
Q1 FY2024Mar 31, 2024$6.00K-98.3%
Q4 FY2023Dec 31, 2023$9.00K-98.2%
Q3 FY2023Sep 30, 2023$15.00K-94.1%
Q2 FY2023Jun 30, 2023$27.00K-92.5%
Q1 FY2023Mar 31, 2023$359.00K-9.1%
Q4 FY2022Dec 31, 2022$500.00K-10.9%
Q3 FY2022Sep 30, 2022$255.00K-75.4%
Q2 FY2022Jun 30, 2022$359.00K-68.3%
Q1 FY2022Mar 31, 2022$395.00K-65.9%
Q4 FY2021Dec 31, 2021$561.00K-71.4%
Q3 FY2021Sep 30, 2021$1.04M-41.1%
Q2 FY2021Jun 30, 2021$1.13M-43.3%
Q1 FY2021Mar 31, 2021$1.16M-48.4%
Q4 FY2020Dec 31, 2020$1.96M+14.6%
Q3 FY2020Sep 30, 2020$1.76M-8.8%
Q2 FY2020Jun 30, 2020$1.99M+2.2%
Q1 FY2020Mar 31, 2020$2.24M+49.1%
Q4 FY2019Dec 31, 2019$1.71M+10.7%
Q3 FY2019Sep 30, 2019$1.93M+44.8%
Q2 FY2019Jun 30, 2019$1.95M+8.7%
Q1 FY2019Mar 31, 2019$1.51M+7.8%
Q4 FY2018Dec 31, 2018$1.55M-28.7%
Q3 FY2018Sep 30, 2018$1.33M-23.7%
Q2 FY2018Jun 30, 2018$1.79M+7.5%
Q1 FY2018Mar 31, 2018$1.40M-23.4%
Q4 FY2017Dec 31, 2017$2.17M+8.8%
Q3 FY2017Sep 30, 2017$1.75M-22.4%
Q2 FY2017Jun 30, 2017$1.67M–
Q1 FY2017Mar 31, 2017$1.82M–
Q4 FY2016Dec 31, 2016$1.99M–
Q3 FY2016Sep 30, 2016$2.26M–

More Arcadia Biosciences figures

See a number that looks wrong?